Canada Life’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,817
| Closed | -$27K | – | 2412 |
|
|
2022
Q3 | $27K | Hold |
1,817
| – | – | ﹤0.01% | 2212 |
|
|
2022
Q2 | $14K | Hold |
1,817
| – | – | ﹤0.01% | 2333 |
|
|
2022
Q1 | $18K | Hold |
1,817
| – | – | ﹤0.01% | 2379 |
|
|
2021
Q4 | $13K | Hold |
1,817
| – | – | ﹤0.01% | 2430 |
|
|
2021
Q3 | $21K | Hold |
1,817
| – | – | ﹤0.01% | 2433 |
|
|
2021
Q2 | $29K | Sell |
1,817
-1,391
| -43% | -$23.9K | ﹤0.01% | 2415 |
|
|
2021
Q1 | $57K | Hold |
3,208
| – | – | ﹤0.01% | 2259 |
|
|
2020
Q4 | $43K | Hold |
3,208
| – | – | ﹤0.01% | 2341 |
|
|
2020
Q3 | $38K | Hold |
3,208
| – | – | ﹤0.01% | 2255 |
|
|
2020
Q2 | $47K | Hold |
3,208
| – | – | ﹤0.01% | 2236 |
|
|
2020
Q1 | $44K | Hold |
3,208
| – | – | ﹤0.01% | 2170 |
|
|
2019
Q4 | $77K | Buy |
+3,208
| New | +$66.4K | ﹤0.01% | 2135 |
|
|
2019
Q3 | – | Sell |
-6,046
| Closed | -$178K | – | 2493 |
|
|
2019
Q2 | $178K | Buy |
6,046
+471
| +8% | +$18.1K | ﹤0.01% | 2058 |
|
|
2019
Q1 | $264K | Buy |
5,575
+1,415
| +34% | +$62.3K | ﹤0.01% | 1807 |
|
|
2018
Q4 | $145K | Hold |
4,160
| – | – | ﹤0.01% | 2024 |
|
|
2018
Q3 | $256K | Hold |
4,160
| – | – | ﹤0.01% | 1912 |
|
|
2018
Q2 | $281K | Hold |
4,160
| – | – | ﹤0.01% | 1884 |
|
|
2018
Q1 | $226K | Hold |
4,160
| – | – | ﹤0.01% | 1934 |
|
|
2017
Q4 | $248K | Hold |
4,160
| – | – | ﹤0.01% | 1909 |
|
|
2017
Q3 | $204K | Buy |
4,160
+1,639
| +65% | +$89.4K | ﹤0.01% | 1949 |
|
|
2017
Q2 | $132K | Hold |
2,521
| – | – | ﹤0.01% | 2025 |
|
|
2017
Q1 | $114K | Hold |
2,521
| – | – | ﹤0.01% | 2080 |
|
|
2016
Q4 | $96K | Sell |
2,521
-2,500
| -50% | -$94.5K | ﹤0.01% | 2127 |
|
|
2016
Q3 | $189K | Buy |
+5,021
| New | +$111K | ﹤0.01% | 1920 |
|
|
2015
Q2 | – | Sell |
-585
| Closed | -$18K | – | 2692 |
|
|
2015
Q1 | $18K | Buy |
585
+145
| +33% | +$4.2K | ﹤0.01% | 2364 |
|
|
2014
Q4 | $13K | Buy |
+440
| New | +$11.2K | ﹤0.01% | 2393 |
|
Canada Life's AERI Position: Q4 2022 in Review
Canada Life sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,817 shares — an estimated $27K sold.
Canada Life first reported a position in AERI in Q4 2014 and held it in 26 quarters. The position peaked at $281K in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Canada Life reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Canada Life sold 1,817 Aerie Pharmaceuticals shares in Q4 2022, an estimated $27K.
- Canada Life first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 26 quarters.
- Canada Life's Aerie Pharmaceuticals position peaked at $281K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.